Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the NovoSeven emergency-use program - Arkin,S.; Cooper,H.A.; Hutter,J.J. (Haemostasis, 1998)